Summary & Overview
HCPCS J0759: Clevidipine Butyrate Injection, 1 mg
HCPCS Level II code J0759 denotes the injection of clevidipine butyrate, 1 mg, an intravenous antihypertensive used for rapid blood pressure control in acute care. This national-level billing code matters because it standardizes reporting for a high-acuity, medication-based service that often requires monitored settings and can drive cost and utilization discussions in hospitals and emergency care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for clevidipine use, typical sites of service, and the billing implications of reporting J0759. The publication outlines common payer coverage considerations, typical service lines that bill the code, and available benchmarks where present. It also highlights policy-related topics relevant to this drug administration code, such as coding clarity for drug unit reporting and site-of-service distinctions.
This summary prepares clinicians, coding professionals, and policy analysts to understand where J0759 fits in hospital and outpatient drug billing, what to expect from major payers, and which operational areas—such as pharmacy administration and monitored units—are most likely to use the code. Data not available in the input is noted where specific payer policies or utilization metrics would otherwise be referenced.
Billing Code Overview
HCPCS Level II code J0759 represents injection, clevidipine butyrate, 1 mg. This code is used to report administration of clevidipine, an intravenous antihypertensive agent indicated for rapid blood pressure control in acute settings. The service type is an injectable pharmacologic therapy administered by infusion or bolus in a monitored clinical environment. The typical site of service includes hospital inpatient, intensive care units, and hospital outpatient settings where rapid titration and hemodynamic monitoring are available.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient is admitted to the perioperative unit for urgent control of severe intraoperative hypertension during vascular surgery. The anesthesiology team initiates a continuous intravenous infusion of clevidipine butyrate to achieve rapid, titratable reduction of blood pressure. The drug is administered as repeated bolus injections or as an infusion prepared from J0759 (injection, clevidipine butyrate, 1 mg) dosed per weight and blood pressure response. Typical clinical workflow: pre-procedure assessment documents indication and baseline vitals; pharmacy compounds and dispenses the product under sterile conditions; anesthesia or critical care staff administers J0759 in the operating room or intensive care unit with continuous hemodynamic monitoring; nursing documents dose, time, vitals, and infusion adjustments; pharmacy or billing captures J0759 units for each milligram administered for accurate reimbursement and inventory tracking.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no service modification applies; typically not appended when a specific modifier is indicated |